Skip to main content
    C

    Context Therapeutics Inc (CNTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.19
    +0.01 (+2.98%)

    Market Cap: $17.26M

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(10/20)
    Avg Surprise
    -17.32%

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$-0.14
    Range$-0.25 - $-0.08
    8 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    Last 12 of 23 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-0.14$-0.25 - $-0.08--8--
    Sep 26
    Reported Nov 4
    		$-0.10$-0.09$-0.16 - $-0.07-11.11%Miss8
    2
    3
    30d
    		+0.0%
    Jun 26
    Reported Aug 5
    		$-0.15$-0.10$-0.10 - $-0.07-50.00%Miss8
    6
    0
    30d
    		-66.7%
    Mar 26
    Reported May 6
    		$-0.09$-0.12$-0.14 - $-0.06+25.00%Beat8
    6
    0
    30d
    		-80.0%
    Dec 25
    Reported Mar 25
    		$-0.14$-0.10$-0.12 - $-0.07-36.59%Miss9
    1
    2
    30d
    		-366.7%
    Sep 25
    Reported Nov 5
    		$-0.10$-0.09$-0.12 - $-0.03-11.11%Miss4
    1
    2
    30d
    		+54.5%
    Jun 25
    Reported Aug 6
    		$-0.09$-0.05$-0.08 - $-0.01-80.00%Miss5
    0
    1
    30d
    		-125.0%
    Mar 25
    Reported May 7
    		$-0.05$-0.06$-0.10 - $-0.04+16.67%Beat3
    1
    1
    30d
    		+78.3%
    Dec 24
    Reported Mar 20
    		$-0.03$-0.06-+47.09%Beat5
    1
    0
    30d
    		+92.9%
    Sep 24
    Reported Nov 6
    		$-0.22$-0.09$-0.16 - $-0.05-144.44%Miss2
    No revisions (30d)
    		+40.5%
    Jun 24
    Reported Aug 7
    		$-0.04$-0.07$-0.08 - $-0.07+42.86%Beat2
    No revisions (30d)
    		+87.1%
    Mar 24
    Reported May 8
    		$-0.23$-0.44$-0.44 - $-0.44+47.73%Beat1
    1
    0
    30d
    		+42.5%
    Dec 23
    Reported Mar 21
    		$-0.42$-0.35$-0.38 - $-0.32-20.00%Miss2
    No revisions (30d)
    		-90.9%

    Key Metrics

    Valuation
    P/E Ratio-0.40EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-76.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio5.81xQuick Ratio5.81x
    Trading Statistics
    Beta1.80Avg Volume1.50M
    52-Week High$3.6252-Week Low$0.19

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.21
    SMA 20$0.23
    SMA 50$0.30
    SMA 200$1.42
    EMA 10$0.21
    EMA 20$0.23
    EMA 50$0.33
    EMA 200$0.94

    MACD

    Line: -0.04Signal: -0.04Hist: 0.00

    ADX

    ADX: 47.9+DI: 7.9-DI: 27.6

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down100.0
    PSAR$0.23

    Bollinger Bands

    Upper Band$0.29
    Lower Band$0.17
    %B Position5357%(Upper)
    Band Width0.22

    RSI (14-Day)

    Neutral
    30.2

    Momentum Oscillators

    Stoch %K12.9
    Stoch %D11.8
    Williams %R-81.6
    ROC (10d)-19.1%
    Momentum-0.05
    CCI (20d)-108.4
    MFI (14d)47.2

    Volatility Measures

    ATR (14d)$0.02(12.6%)
    StdDev (20d)0.03
    Hist Vol77.5%(High)

    Volume Flow

    VWAP$0.19
    OBV-27.0M
    AD Line-65.7M
    CMF (20d)-0.168

    Volume Metrics

    Avg Vol (20d)1.6M
    Vol Ratio0.8x
    VWMA (20d)$0.22

    Pivot Points

    R3$0.23
    R2$0.22
    R1$0.20
    Pivot Point$0.19
    S1$0.18
    S2$0.17
    S3$0.16

    Advanced Oscillators

    TSI-44.94
    Ultimate Osc37.0
    KST-343.33

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$18,952$0
    Cost of Revenue$0$0$32,277$0$0$0$5,136$0$0$0$2,568$0
    Gross Profit$0$0$-32,277$0$0$0N/A$0$0$0$16,384$0
    Operating Expenses$14.97M$9.34M$13.80M$10.61M$9.76M$5.53M$4.31M$18.70M$3.09M$3.82M$6.93M$6.18M
    R&D$12.53M$7.02M$11.84M$8.72M$7.83M$3.46M$2.52M$16.83M$1.38M$1.97M$5.30M$4.49M
    SG&A$2.44M$2.33M$1.96M$1.89M$1.93M$2.07M$1.79M$1.88M$1.70M$1.85M$1.63M$1.70M
    Operating Income$-14,967,491$-9,343,799$-13,804,646$-10,610,480$-9,758,362$-5,529,143$-4,310,422$-18,701,428$-3,088,549$-3,823,501$-6,933,205$-6,180,495
    Interest Income$418,663$520,139$682,484$833,772$903,772$958,517$964,036$1.24M$840,150$152,351$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$-290,440
    Income Before Tax$-14,558,426$-8,680,572$-13,025,607$-9,693,237$-8,827,510$-4,577,261$-3,342,908$-17,459,893$-2,254,506$-3,667,797$-6,769,886$-5,874,686
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-14,558,426$-8,680,572$-13,025,607$-9,693,237$-8,827,510$-4,577,261$-3,342,908$-17,459,893$-2,254,506$-3,667,797$-6,769,886$-5,874,686
    EBITDA$-14,931,616$-9,164,606$-13,704,026$-10,495,486$-9,700,492$-5,505,711$-4,304,010$-3,934,266$-3,092,088$-3,817,580$-6,992,037$-6,154,515
    EBIT$-14,977,089$-9,200,711$-13,708,091$-10,527,009$-9,731,282$-5,535,778$-4,306,944$-18,703,580$-3,094,656$-3,820,148$-6,994,605$-6,165,126
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CNTX

    News

    Context Therapeutics Inc. (CNTX) Seasonal returns chart

    This article provides a seasonal returns chart for Context Therapeutics Inc. (CNTX), detailing the average monthly price return from 2021 to 2026. It includes current stock data such as the real-time price, daily change...

    Yahoo Finance Australia•11/1/26•Neutral

    Context Therapeutics Inc. (CNTX) Seasonal returns chart

    This article from Yahoo Finance presents a seasonal returns chart for Context Therapeutics Inc. (CNTX). The chart displays the average monthly price return for the company's stock between 2021 and 2026. As...

    Yahoo Finance UK•10/31/26•Neutral

    Context Therapeutics Inc. (CNTX) Stock Price, News, Quote & History

    Context Therapeutics Inc. (CNTX) closed at $0.1891, down 6.25% on October 30, with a market capitalization of $17.374 million. The clinical-stage biopharmaceutical company focuses on developing products for solid tumors...

    Yahoo! Finance Canada•10/30/26•Somewhat-Bearish

    Context Therapeutics Inc. Estimates – NASDAQ:CNTX

    The article provides a brief overview of Context Therapeutics Inc. (NASDAQ: CNTX) financials and estimates available on TradingView. It highlights where users can explore reported financial data, analyst estimates...

    TradingView•10/23/26•Neutral

    Context Therapeutics Inc (CNTX-Q) Stock Price and News

    This page provides stock price and news updates for Context Therapeutics Inc (CNTX-Q), a women's oncology company focused on developing treatments for hormone-driven cancers. It includes real-time stock data...

    The Globe and Mail•10/1/26•Neutral

    CNTX Valuation and Fair Value

    P/E
    -0.4x
    P/B
    0.5x
    See GNG's fair value

    CNTX Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -76.1%

    CNTX Competitors

    CompanyTicker
    Pasithea Therapeutics CorpKTTA
    Jasper Therapeutics IncJSPR
    Estrella Immunopharma Inc.ESLA
    Retractable Technologies IncRVP
    Sensei Biotherapeutics IncSNSE
    Pluri Inc.PLUR
    Picard Medical, Inc.PMI
    Lifeward Ltd.LFWD

    Sector: Healthcare

    CNTX Analyst Ratings

    Consensus
    Buy
    Analysts
    10
    Strong Buy
    3
    Buy
    6
    Hold
    1
    Sell
    0
    Strong Sell
    0

    CNTX Bull Case vs Bear Case

    Bull case

    • 90.0% of CNTX's analyst ratings are Buy or Strong Buy.

    Bear case

    • CNTX beat EPS estimates in 37.5% of its last 8 reported quarters.

    CNTX Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -12.5%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $-0.14

    CNTX Earnings Date

    CNTX reports Mar 22, 2027, after the close. The date is estimated.

    CNTX ETF Holders

    GNG tracks 3 ETFs that hold CNTX. The largest weights:

    1. Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
    2. Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
    3. Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
    Open the ETF Stock Exposure tool for CNTX

    See insider activity

    Frequently Asked Questions About CNTX

    When does CNTX report earnings?

    Context Therapeutics Inc (CNTX) is expected to report earnings on Mar 22, 2027.

    Does CNTX pay dividends?

    Context Therapeutics Inc (CNTX) does not currently pay a regular dividend.

    What is CNTX's market cap?

    Context Therapeutics Inc (CNTX) has a market capitalization of $17.26M with a current stock price of $0.19.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In